Chinese researchers have developed a heavy-ion medical accelerator to be used in radiotherapy for cancer, researchers said Thursday. A recent test of the machine's beam was successful, marking the end of China's dependence on imported ...
Tags: Heavy-ion, Medical Accelerator
Findings suggest drugs can now be developed to stall the growth of K-Ras cancers, previously deemed impossible to treat NYU Langone Medical Center researchers have found a biological weakness in the workings of the most commonly mutated ...
Tags: K-Ras, DNA, radiation, Mutated Gene
In research that could ultimately lead to many new medicines, scientists from the Florida campus of The Scripps Research Institute (TSRI) have developed a potentially general approach to design drugs from genome sequence. As a proof of ...
Tags: Identify New Drug Candidates, unparalleled selectivity, cell permeable
Scientists at the University of Kansas Medical Center have determined that high doses of vitamin C, administered intravenously with traditional chemotherapy, helped kill cancer cells while reducing the toxic effects of chemotherapy for some ...
TUESDAY Feb. 11, 2014, 2014 -- Experimental glasses that seem to improve a doctor's ability to see cancer cells during surgery may help reduce cancer patients' need for follow-up operations, according to a new study. The researchers said ...
Tags: cancer, Experimental Eyewear, high-powered magnification
Researchers in the Cedars-Sinai Samuel Oschin Comprehensive Cancer Institute discovered in pre-clinical models that dormant prostate cancer cells found in bone tissue can be reawakened, causing metastasis to other parts of the body. ...
Tags: Prostate Cancer Cells, reawakened, preventing the spread of disease
Clinical trials investigating new uses for the anti-cancer drug Avastin have produced mixed results. When combined with standard chemotherapy, Avastin extended the survival of patients with advanced cervical cancer by nearly four months, ...
Adamis Pharmaceuticals has announced an important addition to its intellectual property with receipt of a notice of allowance of patent claims supporting its cancer immunotherapy portfolio in the US. Notice of allowance is the final step ...
Tags: Cancer Immunology, Cancer, Cancer cure
Smokers and other people at high risk for lung cancer could make matters worse if they take antioxidant supplements, a new study of rodents suggests. Antioxidants appear to accelerate cancer progression by short-circuiting one of the ...
Tags: antioxidants, health, Cancer
Queensland scientists have made significant inroads into our understanding of the deadliest form of ovarian cancer after identifying two enzymes that make it resistant to chemotherapy. There is currently no proven screening test or method ...
Tags: QUT, ovarian cancer, Katie Clift, 3D modelling
Stem cells can turn into heart cells, skin cells can mutate to cancer cells; even cells of the same tissue type exhibit small heterogeneities. Scientists use single-cell analysis to investigate these heterogeneities. But the method is still ...
Tags: Consumer Electronics, Electronics, Biological Single-Cell
Researchers at the Swiss Federal Institute of Technology in Zurich have deciphered the structure of part of the ribosome found in mitochondria, the power plants of the cell. The scientists were able to benefit from advancements in the field ...
Tags: Consumer Electronics, Electronics
Some cells fail by chance, and not due to a genetic defect, to properly initiate the molecular processes for the breakdown of sugar. These cells are unable to grow and subsequently die. This discovery was done by a multidisciplinary team ...
A collaboration between National Cancer Centre Singapore (NCCS) and Clearbridge BioMedics, in partnership with the Pathology Department at Singapore General Hospital (SGH) has resulted in the establishment of the region's first Circulating ...
Patients with advanced pancreatic cancer, one of the most deadly malignancies, may live a little longer when treated with two therapeutic vaccines, new research suggests. In a study of 90 patients, this combination approach -- GVAX ...
Tags: a